The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients

Abstract

The present meta-analysis generally demonstrates no association between beta-blocker use and cancer prognosis except for CSS in all population groups examined. High-quality studies should be conducted to confirm this conclusion in future.